SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000893838-06-000049
Filing Date
2006-05-03
Accepted
2006-05-03 21:00:00
Documents
1
Period of Report
2006-05-01

Document Format Files

Seq Description Document Type Size
1 rexform4cheong_ex.html 4  
1 rexform4cheong_ex.xml 4 3718
  Complete submission text file 0000893838-06-000049.txt   5640
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address REXAHN PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 240-268-5300
Cheong Kwang Soo (Reporting) CIK: 0001361686 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50590 | Film No.: 06805768